Drug class
Second-generation H1 antihistamine; mast-cell stabilising and antiallergic agent
Mechanism of action
Antagonises histamine H1 receptors and inhibits mediator release from mast cells and basophils, including histamine, leukotrienes and prostaglandins. It also inhibits selected calcium-dependent degranulation pathways.
General use cases
- Symptomatic treatment of allergic rhinitis, chronic urticaria and selected allergic skin disorders in countries where oxatomide is authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
